CHAMPIONS ONCOLOGY, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.61 million shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-07-31 was 2.61M shares, a 3.22% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-07-31 was 2.53M shares, a 123.73% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-07-31 was 1.13M shares, a 35.95% decline year-over-year.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-07-31 was 1.77M shares, a 2.59% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 2.64M shares, a 1989.24% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 126.35K shares, a 93.42% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.92M shares, a 8.10% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.78M shares, a 7.08% increase from fiscal 2022.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 2.61M shares 10-Q · filed 2026-09-11 | |||||||
| 2026-04-30 | 2.64M shares 10-K · filed 2026-07-27 | |||||||
| 2026-01-31 | 2.55M shares 10-Q · filed 2026-03-12 | |||||||
| 2025-10-31 | 2.42M shares 10-Q · filed 2025-12-15 | |||||||
| 2025-07-31 | 2.53M shares 10-Q · filed 2026-09-11 | |||||||
| 2025-04-30 | 126.35K shares 10-K · filed 2026-07-27 | |||||||
| 2025-01-31 | 499.49K shares 10-Q · filed 2026-03-12 | 499.48K shares 10-Q · filed 2025-03-17 | ||||||
| 2024-10-31 | 907.98K shares 10-Q · filed 2025-12-15 | |||||||
| 2024-07-31 | 1.13M shares 10-Q · filed 2025-09-15 | |||||||
| 2024-04-30 | 1.92M shares 10-K · filed 2025-07-23 | |||||||
| 2024-01-31 | 1.90M shares 10-Q · filed 2025-03-17 | |||||||
| 2023-10-31 | 1.83M shares 10-Q · filed 2024-12-16 | |||||||
| 2023-07-31 | 1.77M shares 10-Q · filed 2024-09-13 | |||||||
| 2023-04-30 | 1.78M shares 10-K · filed 2024-07-19 | |||||||
| 2023-01-31 | 1.78M shares 10-Q · filed 2024-03-15 | |||||||
| 2022-10-31 | 1.68M shares 10-Q · filed 2023-12-13 | |||||||
| 2022-07-31 | 1.72M shares 10-Q · filed 2023-09-13 | |||||||
| 2022-04-30 | 1.66M shares 10-K · filed 2023-07-24 | 1.33M shares 10-K · filed 2022-07-22 | ||||||
| 2022-01-31 | 1.68M shares 10-Q · filed 2023-03-16 | |||||||
| 2021-10-31 | 1.63M shares 10-Q · filed 2022-12-13 | |||||||
| 2021-07-31 | 1.73M shares 10-Q · filed 2022-09-12 | |||||||
| 2021-04-30 | 1.65M shares 10-K · filed 2022-07-22 | |||||||
| 2021-01-31 | 1.69M shares 10-Q · filed 2022-03-15 | |||||||
| 2020-10-31 | 1.65M shares 10-Q · filed 2021-12-13 | |||||||
| 2020-07-31 | 2.28M shares 10-Q · filed 2021-09-13 | |||||||
| 2020-04-30 | 2.27M shares 10-K · filed 2021-07-26 | |||||||
| 2020-01-31 | 4.04M shares 10-Q · filed 2021-03-15 | |||||||
| 2019-10-31 | 4.12M shares 10-Q · filed 2020-12-14 | |||||||
| 2019-07-31 | 4.04M shares 10-Q · filed 2020-09-14 | |||||||
| 2019-04-30 | 4.10M shares 10-K · filed 2020-07-28 | |||||||
| 2019-01-31 | 4.16M shares 10-Q · filed 2020-03-16 | |||||||
| 2018-10-31 | 4.35M shares 10-Q · filed 2019-12-16 | |||||||
| 2018-07-31 | 4.69M shares 10-Q · filed 2019-09-16 | |||||||
| 2018-04-30 | 4.71M shares 10-K · filed 2019-07-29 | |||||||
| 2018-01-31 | 4.52M shares 10-Q · filed 2019-03-18 | |||||||
| 2017-10-31 | 4.50M shares 10-Q · filed 2018-12-17 | |||||||
| 2017-07-31 | 4.51M shares 10-Q · filed 2018-09-14 | |||||||
| 2017-04-30 | 4.31M shares 10-K · filed 2018-07-30 | |||||||
| 2017-01-31 | 4.42M shares 10-Q · filed 2018-03-19 | |||||||
| 2016-10-31 | 4.56M shares 10-Q · filed 2017-12-15 | |||||||
| 2016-07-31 | 4.26M shares 10-Q · filed 2017-09-14 | |||||||
| 2016-04-30 | 4.32M shares 10-K · filed 2017-07-28 | |||||||
| 2016-01-31 | 4.32M shares 10-Q · filed 2017-03-17 | |||||||
| 2015-10-31 | 4.09M shares 10-Q · filed 2016-12-14 | |||||||
| 2015-07-31 | 4.12M shares 10-Q · filed 2016-09-14 | |||||||
| 2015-04-30 | 4.11M shares 10-K · filed 2016-07-29 | 49.37M shares 10-K · filed 2015-07-29 | ||||||
| 2015-01-31 | 2.26M shares 10-Q · filed 2016-03-16 | 27.12M shares 10-Q · filed 2015-03-17 | ||||||
| 2014-10-31 | 2.28M shares 10-Q · filed 2015-12-15 | 27.38M shares 10-Q · filed 2014-12-15 | ||||||
| 2014-07-31 | 2.22M shares 10-Q · filed 2015-09-11 | 26.66M shares 10-Q · filed 2014-09-12 | ||||||
| 2014-04-30 | 26.63M shares 10-K · filed 2015-07-29 | |||||||
| 2014-01-31 | 25.91M shares 10-Q · filed 2015-03-17 | |||||||
| 2013-10-31 | 18.75M shares 10-Q · filed 2014-12-15 | |||||||
| 2013-07-31 | 17.46M shares 10-Q · filed 2014-09-12 | |||||||
| 2013-04-30 | 17.22M shares 10-K · filed 2014-07-28 | |||||||
| 2013-01-31 | 18.37M shares 10-Q · filed 2014-03-14 | |||||||
| 2012-10-31 | 16.06M shares 10-Q · filed 2013-12-13 | |||||||
| 2012-07-31 | 16.53M shares 10-Q · filed 2013-09-13 | |||||||
| 2012-04-30 | 16.31M shares 10-K · filed 2013-07-26 | |||||||
| 2012-01-31 | 16.52M shares 10-Q · filed 2013-03-13 | |||||||
| 2011-10-31 | 16.03M shares 10-Q · filed 2012-12-13 | |||||||
| 2011-07-31 | 16.46M shares 10-Q · filed 2012-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |